We used a syngeneic HOXA9–MEIS1 retroviral overexpression transplant model that recapitulates much of MLL-AF9 AML biology while retaining applicability to non-MLL-rearranged AML types with prominent HOXA9 and MEIS1 activity24. Here, KMT2A is linked to acute myeloid leukemia.